Compare $2257.HK vs $SPRY | Chartloom

Compare

$2257.HK vs $SPRY

2257.HK

Error

SPRY

ARS Pharmaceuticals Inc

Compare $2257.HK vs $SPRY

2257.HK

Error

SPRYARS Pharmaceuticals Inc

2257.HK

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

SPRYARS Pharmaceuticals Inc

Market cap

$420M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.81x

Rev growth (TTM)

4.1%

YTD performance

-63.2%

52W performance

-61.9%

FCF yield

-46.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

2257.HK

SPRY

Not enough overlapping price history for this window.

Detailed metrics comparison

2257.HK

SPRY

ARS Pharmaceuticals Inc

Market Cap

2257.HK

SPRY$420M

Enterprise Value

2257.HK

SPRY$509M

Price

2257.HK

SPRY$4.23

P/E Ratio

2257.HK

SPRYN/A

P/S Ratio

2257.HK

SPRY3.59x

EV/Sales

2257.HK

SPRY4.35x

EV/EBITDA

2257.HK

SPRY0.00x

P/B Ratio

2257.HK

SPRY32.35x

P/FCF Ratio

2257.HK

SPRYN/A

EV/FCF

2257.HK

SPRY-2.59x

PEG Ratio

2257.HK

SPRYN/A

Forward P/E (NTM)

2257.HK

SPRYN/A

Forward P/S (NTM)

2257.HK

SPRY2.81x

Revenue (TTM)

2257.HK

SPRY$117M

Revenue Growth (YoY)

2257.HK

SPRY4.1%

Forward Rev Growth

2257.HK

SPRY46.9%

Gross Margin (TTM)

2257.HK

SPRY71.4%

Operating Margin (TTM)

2257.HK

SPRY0.0%

EBITDA Margin (TTM)

2257.HK

SPRY-183.6%

Net Margin (TTM)

2257.HK

SPRY-184.2%

FCF Margin (TTM)

2257.HK

SPRY-168.1%

Net Income (TTM)

2257.HK

SPRY$-215M

FCF (TTM)

2257.HK

SPRY$-197M

EPS (TTM)

2257.HK

SPRY-$2.17

ROE (TTM)

2257.HK

SPRY-25667.0%

ROA (TTM)

2257.HK

SPRY-6963.0%

ROIC (TTM)

2257.HK

SPRY-11943.0%

Cash

2257.HK

SPRY$8M

Debt

2257.HK

SPRY$97M

Net Cash/Debt

2257.HK

SPRY$-89M

Current Ratio (TTM)

2257.HK

SPRY3.48x

Quick Ratio (TTM)

2257.HK

SPRY3.13x

Debt/Equity (TTM)

2257.HK

SPRY7.73x

Debt/Assets (TTM)

2257.HK

SPRY0.0%

Interest Coverage (TTM)

2257.HK

SPRYN/A

Net Debt/EBITDA (TTM)

2257.HK

SPRY0.00x

Beta

2257.HK

SPRY0.92

52W Performance

2257.HK

SPRY-61.9%

YTD Performance

2257.HK

SPRY-63.2%

% from 52W High

2257.HK

SPRY-67.8%

% from 52W Low

2257.HK

SPRY6.1%

Asset Turnover (TTM)

2257.HK

SPRY0.38x

FCF Yield (TTM)

2257.HK

SPRY-46.8%

Earnings Yield (TTM)

2257.HK

SPRY-51.3%

Dividend Yield (TTM)

2257.HK

SPRYN/A

Rule of 40

2257.HK

SPRY-164.1

EV/GP/RG

2257.HK

SPRY0.16

Ticker research

View 2257.HK research View SPRY research

Metric	2257.HK	SPRY ARS Pharmaceuticals Inc
Market & Valuation
Market Cap		$420M
Enterprise Value		$509M
Price		$4.23
P/E Ratio		N/A
P/S Ratio		3.59x
EV/Sales		4.35x
EV/EBITDA		0.00x
P/B Ratio		32.35x
P/FCF Ratio		N/A
EV/FCF		-2.59x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		2.81x
Revenue & Growth
Revenue (TTM)		$117M
Revenue Growth (YoY)		4.1%
Forward Rev Growth		46.9%
Profitability
Gross Margin (TTM)		71.4%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-183.6%
Net Margin (TTM)		-184.2%
FCF Margin (TTM)		-168.1%
Net Income (TTM)		$-215M
FCF (TTM)		$-197M
EPS (TTM)		-$2.17
ROE (TTM)		-25667.0%
ROA (TTM)		-6963.0%
ROIC (TTM)		-11943.0%
Financial Health
Cash		$8M
Debt		$97M
Net Cash/Debt		$-89M
Current Ratio (TTM)		3.48x
Quick Ratio (TTM)		3.13x
Debt/Equity (TTM)		7.73x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.92
52W Performance		-61.9%
YTD Performance		-63.2%
% from 52W High		-67.8%
% from 52W Low		6.1%
Efficiency & Yields
Asset Turnover (TTM)		0.38x
FCF Yield (TTM)		-46.8%
Earnings Yield (TTM)		-51.3%
Dividend Yield (TTM)		N/A
Other
Rule of 40		-164.1
EV/GP/RG		0.16
Ticker research	View 2257.HK research	View SPRY research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

2257.HK

SPRY

ARS Pharmaceuticals Inc

Market Cap

2257.HK

SPRY$420M

Enterprise Value

2257.HK

SPRY$509M

Price

2257.HK

SPRY$4.23

P/E Ratio

2257.HK

SPRYN/A

P/S Ratio

2257.HK

SPRY3.59x

EV/Sales

2257.HK

SPRY4.35x

EV/EBITDA

2257.HK

SPRY0.00x

P/B Ratio

2257.HK

SPRY32.35x

P/FCF Ratio

2257.HK

SPRYN/A

EV/FCF

2257.HK

SPRY-2.59x

PEG Ratio

2257.HK

SPRYN/A

Forward P/E (NTM)

2257.HK

SPRYN/A

Forward P/S (NTM)

2257.HK

SPRY2.81x

Revenue (TTM)

2257.HK

SPRY$117M

Revenue Growth (YoY)

2257.HK

SPRY4.1%

Forward Rev Growth

2257.HK

SPRY46.9%

Gross Margin (TTM)

2257.HK

SPRY71.4%

Operating Margin (TTM)

2257.HK

SPRY0.0%

EBITDA Margin (TTM)

2257.HK

SPRY-183.6%

Net Margin (TTM)

2257.HK

SPRY-184.2%

FCF Margin (TTM)

2257.HK

SPRY-168.1%

Net Income (TTM)

2257.HK

SPRY$-215M

FCF (TTM)

2257.HK

SPRY$-197M

EPS (TTM)

2257.HK

SPRY-$2.17

ROE (TTM)

2257.HK

SPRY-25667.0%

ROA (TTM)

2257.HK

SPRY-6963.0%

ROIC (TTM)

2257.HK

SPRY-11943.0%

Cash

2257.HK

SPRY$8M

Debt

2257.HK

SPRY$97M

Net Cash/Debt

2257.HK

SPRY$-89M

Current Ratio (TTM)

2257.HK

SPRY3.48x

Quick Ratio (TTM)

2257.HK

SPRY3.13x

Debt/Equity (TTM)

2257.HK

SPRY7.73x

Debt/Assets (TTM)

2257.HK

SPRY0.0%

Interest Coverage (TTM)

2257.HK

SPRYN/A

Net Debt/EBITDA (TTM)

2257.HK

SPRY0.00x

Beta

2257.HK

SPRY0.92

52W Performance

2257.HK

SPRY-61.9%

YTD Performance

2257.HK

SPRY-63.2%

% from 52W High

2257.HK

SPRY-67.8%

% from 52W Low

2257.HK

SPRY6.1%

Asset Turnover (TTM)

2257.HK

SPRY0.38x

FCF Yield (TTM)

2257.HK

SPRY-46.8%

Earnings Yield (TTM)

2257.HK

SPRY-51.3%

Dividend Yield (TTM)

2257.HK

SPRYN/A

Rule of 40

2257.HK

SPRY-164.1

EV/GP/RG

2257.HK

SPRY0.16

Ticker research

View 2257.HK research View SPRY research

Metric	2257.HK	SPRY ARS Pharmaceuticals Inc
Market & Valuation
Market Cap		$420M
Enterprise Value		$509M
Price		$4.23
P/E Ratio		N/A
P/S Ratio		3.59x
EV/Sales		4.35x
EV/EBITDA		0.00x
P/B Ratio		32.35x
P/FCF Ratio		N/A
EV/FCF		-2.59x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		2.81x
Revenue & Growth
Revenue (TTM)		$117M
Revenue Growth (YoY)		4.1%
Forward Rev Growth		46.9%
Profitability
Gross Margin (TTM)		71.4%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-183.6%
Net Margin (TTM)		-184.2%
FCF Margin (TTM)		-168.1%
Net Income (TTM)		$-215M
FCF (TTM)		$-197M
EPS (TTM)		-$2.17
ROE (TTM)		-25667.0%
ROA (TTM)		-6963.0%
ROIC (TTM)		-11943.0%
Financial Health
Cash		$8M
Debt		$97M
Net Cash/Debt		$-89M
Current Ratio (TTM)		3.48x
Quick Ratio (TTM)		3.13x
Debt/Equity (TTM)		7.73x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.92
52W Performance		-61.9%
YTD Performance		-63.2%
% from 52W High		-67.8%
% from 52W Low		6.1%
Efficiency & Yields
Asset Turnover (TTM)		0.38x
FCF Yield (TTM)		-46.8%
Earnings Yield (TTM)		-51.3%
Dividend Yield (TTM)		N/A
Other
Rule of 40		-164.1
EV/GP/RG		0.16
Ticker research	View 2257.HK research	View SPRY research